Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yeokyeong Shin

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 8, 2025
Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1Ji-Seon Jeong, Yeokyeong Shin, Shinkyo Yoon, et al.
European Radiology|October 22, 2024
Prognostic value of interim [<sup>68</sup>Ga]Ga-DOTA-TOC PET/CT in patients with neuroendocrine tumour who underwent peptide receptor radionuclide therapyEonwoo Shin, Yong-Il Kim, Changhoon Yoo, et al.
Targeted Oncology|December 18, 2023
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in KoreaYeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, et al.
Korean Journal of Radiology|March 31, 2026
Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine TherapyMinseung Suh, Jeongryul Ryu, Hojin Song, et al.
Targeted Oncology|December 28, 2025
Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic PotentialYeokyeong Shin, Jinho Shin, Hyehyun Jeong, et al.
Cancer Research and Treatment|March 6, 2025
Ten-Year Follow-Up Clinical Outcomes and the Role of Adjuvant Chemotherapy in HER2-Positive Patients with Microinvasive Breast CancerYeokyeong Shin, Soo-Young Lee, Hyehyun Jeong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 23, 2024
Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinomaHyunseok Yoon, Yeokyeong Shin, Baek-Yeol Ryoo, et al.
Neuro-Oncology|December 3, 2025
A Novel Prognostic Model for Primary CNS Lymphoma Incorporating Clinico-Laboratory ParametersYeokyeong Shin, Jaewon Hyung, Shin Kim, et al.
Journal of Breast Cancer|April 1, 2026
A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast CancerShinyoung Lee, Hyehyun Jeong, Yeokyeong Shin, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
European Journal of Cancer (Oxford, England : 1990)|November 8, 2025
Molecular and Clinical characteristics of ROS1 Fusion Variants in ROS1-rearranged Cancers: A Defined Role of Fusion Partners and Breakpoints of ROS1Ji-Seon Jeong, Yeokyeong Shin, Shinkyo Yoon, et al.
European Radiology|October 22, 2024
Prognostic value of interim [<sup>68</sup>Ga]Ga-DOTA-TOC PET/CT in patients with neuroendocrine tumour who underwent peptide receptor radionuclide therapyEonwoo Shin, Yong-Il Kim, Changhoon Yoo, et al.
Targeted Oncology|December 18, 2023
Efficacy and Safety of Lu-177 DOTATATE Peptide Receptor Radionuclide Therapy in Patients with Unresectable or Metastatic Neuroendocrine Tumors in KoreaYeokyeong Shin, Bo Hyun Moon, Baek-Yeol Ryoo, et al.
Korean Journal of Radiology|March 31, 2026
Prognostic Significance of Pretreatment ¹⁸F-FDG PET/CT Parameters in Patients With ER+/HER2- Metastatic Breast Cancer Treated With CDK4/6 Inhibitors Plus Endocrine TherapyMinseung Suh, Jeongryul Ryu, Hojin Song, et al.
Targeted Oncology|December 28, 2025
Claudin-18.2 and Trop-2 as Emerging Biomarkers in Biliary Tract Cancers: Expression Analysis and Therapeutic PotentialYeokyeong Shin, Jinho Shin, Hyehyun Jeong, et al.
Cancer Research and Treatment|March 6, 2025
Ten-Year Follow-Up Clinical Outcomes and the Role of Adjuvant Chemotherapy in HER2-Positive Patients with Microinvasive Breast CancerYeokyeong Shin, Soo-Young Lee, Hyehyun Jeong, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|February 23, 2024
Clinical outcomes of second-line therapy following disease progression on first-line modified FOLFIRINOX for borderline resectable and locally advanced pancreatic adenocarcinomaHyunseok Yoon, Yeokyeong Shin, Baek-Yeol Ryoo, et al.
Neuro-Oncology|December 3, 2025
A Novel Prognostic Model for Primary CNS Lymphoma Incorporating Clinico-Laboratory ParametersYeokyeong Shin, Jaewon Hyung, Shin Kim, et al.
Journal of Breast Cancer|April 1, 2026
A Real-World Efficacy and Safety of KEYNOTE-522 Regimen in Patients With Early Triple-Negative Breast CancerShinyoung Lee, Hyehyun Jeong, Yeokyeong Shin, et al.
Pageof 1